CNS & Neurological Disorders - Drug Targets

Formerly Current Drug Targets - CNS & Neurological Disorders

Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 14 Issue: 2, March 2015



Meet the Editorial Board free to download

Volume:14   Issue: 2
Pp: 151-151
Mohammad Amjad Kamal
DOI: 10.2174/187152731402150305113014
Published on: 04 March, 2015



Commentary (Changes of Synaptic Plasticity in Multiple Sclerosis)

Volume:14   Issue: 2
Pp: 152-154
Ti-Fei Yuan, Chunlei Shan and Oscar Arias-Carrion
DOI: 10.2174/1871527313666141114203620
Published on: 14 November, 2014



Editorial (Thematic Issue: MiRNAcles in the Brain: What to Wish and What to Fear) free to download

Volume:14   Issue: 2
Pp: 155-156
Stephen D. Skaper and Cinzia Volonte
DOI: 10.2174/187152731402150305113941
Published on: 04 March, 2015

The Blood-Brain Barrier in Multiple Sclerosis: microRNAs as Key Regulators

Volume:14   Issue: 2
Pp: 157-167
Wouter W. Kamphuis, Claudio Derada Troletti, Aric Reijerkerk, Ignacio A. Romero and Helga E. de Vries
DOI: 10.2174/1871527314666150116125246
Published on: 16 January, 2015

MicroRNA Landscape in Alzheimer’s Disease

Volume:14   Issue: 2
Pp: 168-175
Carlo Cogoni, Francesca Ruberti and Christian Barbato
DOI: 10.2174/1871527314666150116123305
Published on: 16 January, 2015

MicroRNAs in CAG Trinucleotide Repeat Expansion Disorders: an Integrated Review of the Literature

Volume:14   Issue: 2
Pp: 176-193
Laura Dumitrescu and Bogdan O. Popescu
DOI: 10.2174/1871527314666150116124715
Published on: 16 January, 2015

MicroRNAs: Newcomers into the ALS Picture

Volume:14   Issue: 2
Pp: 194-207
Cinzia Volonte, Savina Apolloni and Chiara Parisi
DOI: 10.2174/1871527314666150116125506
Published on: 16 January, 2015

The Emerging Role of MicroRNA in Schizophrenia

Volume:14   Issue: 2
Pp: 208-221
Viviana Caputo, Andrea Ciolfi, Simone Macri and Antonio Pizzuti
DOI: 10.2174/1871527314666150116124253
Published on: 16 January, 2015

MicroRNAs in Glioblastoma: Role in Pathogenesis and Opportunities for Targeted Therapies

Volume:14   Issue: 2
Pp: 222-238
Pedro M. Costa, Ana L. Cardoso, Miguel Mano and Maria C. Pedroso de Lima
DOI: 10.2174/1871527314666150116123610
Published on: 16 January, 2015

MicroRNAs: Emerging Role in the Endogenous μ Opioid System

Volume:14   Issue: 2
Pp: 239-250
Massmo Barbierato, Morena Zusso, Stephen D. Skaper and Pietro Giusti
DOI: 10.2174/1871527314666150116123932
Published on: 16 January, 2015

Interferon-γ-Induced Neurotoxicity of Human Astrocytes

Volume:14   Issue: 2
Pp: 251-256
Sadayuki Hashioka, Edith G. McGeer, Tsuyoshi Miyaoka, Rei Wake, Jun Horiguchi and Patrick L. McGeer
DOI: 10.2174/1871527314666150217122305
Published on: 17 February, 2015

Vascular Risk Factors and Alzheimer’s Disease Pathogenesis: Are Conventional Pharmacological Approaches Protective For Cognitive Decline Progression?

Volume:14   Issue: 2
Pp: 257-269
Apostolos Safouris, Theodora Psaltopoulou, Theodoros N. Sergentanis, Eleni Boutati, Elisabeth Kapaki and Georgios Tsivgoulis
DOI: 10.2174/1871527314666150217123147
Published on: 17 February, 2015

Potential Targets for the Development of Novel Antidepressants: Future Perspectives

Volume:14   Issue: 2
Pp: 270-281
Vishnu N. Thakare and Bhoomika M. Patel
DOI: 10.2174/1871527313666140806121648
Published on: 06 August, 2014

Silymarin Extends Lifespan and Reduces Proteotoxicity in C. elegans Alzheimer’s Model

Volume:14   Issue: 2
Pp: 295-302
Jitendra Kumar, Kyung-Chae Park, Anjali Awasthi and Birendra Prasad
DOI: 10.2174/1871527314666150116110212
Published on: 15 January, 2015